author-photo

Suzanne Kafaja

University of California, Los Angeles

42

Papers

2287

Citations

Citation Trend

Filter By

Papers (28) Sort By

Journal Conference Others

OP0171 PHASE 3 TRIAL OF LENABASUM, A CB2 AGONIST, FOR THE TREATMENT OF DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS (DCSSC)

2021 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Pain levels and associated factors in the Scleroderma Patient-centered Intervention Network (SPIN) cohort: a multicentre cross-sectional study

2021
Show All
- Source
- Cite
- Save
Citations (1)
The Scleroderma Patient-centered Intervention Network Self-Management (SPIN-SELF) Program: protocol for a two-arm parallel partially nested randomized controlled feasibility trial with progression to full-scale trial.

2021 Trials
Show All
- Source
- Cite
- Save
Citations (0)
Responsiveness of the University of California Los Angeles Scleroderma Clinical Trial Consortium gastrointestinal tract 2.0 (UCLA-SCTC-GIT 2.0)to change in scleroderma patients

2021
Show All
- Source
- Cite
- Save
Citations (0)
Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts.

2020 Clinical Rheumatology
Show All
- Source
- Cite
- Save
Citations (1)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

2020 The Lancet Respiratory Medicine
Show All
- Source
- Cite
- Save
Citations (80)
Protocol for a partially nested randomised controlled trial to evaluate the effectiveness of the scleroderma patient-centered intervention network COVID-19 home-isolation activities together (SPIN-CHAT) program to reduce anxiety among at-risk scleroderma patients.

2020 Journal of Psychosomatic Research
Show All
- Source
- Cite
- Save
Citations (15)
OP0068 ABATACEPT IN EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS— RESULTS OF A PHASE 2 INVESTIGATOR-INITIATED, MULTICENTER, DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED TRIAL

2019 Annals of the Rheumatic Diseases
Show All
- Source
- Cite
- Save
Citations (5)
Mo1613 – Wireless Motility Capsule Evaluation of Regional and Whole Gut Transit Times in Patients with Systemic Sclerosis and Correlation with a Validated Disease-Specific Gastrointestinal Symptom Questionnaire

2019 Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis – Results of a Phase 2 Investigator‐Initiated, Multicenter, Double‐Blind Randomized Placebo‐Controlled Trial

2019 Arthritis & Rheumatism
Show All
- Source
- Cite
- Save
Citations (91)